Breast Cancer Drug Analysis Flags Dementia Signals for Anastrozole in Women Over 50
A large pharmacovigilance analysis of FDA adverse event reports found no overall dementia risk signal for endocrine and targeted breast ...
A large pharmacovigilance analysis of FDA adverse event reports found no overall dementia risk signal for endocrine and targeted breast ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.